Recipharm to produce some of Moderna's COVID-19 vaccine in France

Reuters
Paris, France Published: Nov 25, 2020, 03.16 PM(IST)

Vials with a sticker reading "COVID-19/Coronavirus vaccine/Injection only" and a syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. Photograph:( Reuters )

Story highlights

Recipharm, a contract development and manufacturing organisation (CDMO) that has four plants in France, said it had signed a letter of intent with the U.S. company and that it was expecting a final agreement to be reached next month.

Sweden`s Recipharm will produce doses of Moderna`s COVID-19 vaccine candidate in central France, the company said on Wednesday, adding it had started recruiting and investing to start manufacturing.

Recipharm, a contract development and manufacturing organisation (CDMO) that has four plants in France, said it had signed a letter of intent with the U.S. company and that it was expecting a final agreement to be reached next month.

The doses would be produced at Recipharm`s facility in Monts.
Financial details were not disclosed.

The European Union struck a deal on Tuesday for up to 160 million doses of Moderna`s vaccine candidate, taking the bloc`s potential stock of COVID-19 shots to nearly 2 billion.

Last week, Moderna said its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial.

There is no internationally approved vaccine yet to prevent COVID-19 caused by the new coronavirus which has killed more than 1.4 million people and derailed the world economy.

Read in App